CFO Erin Colgan To Step Down
Colgan has voluntarily decided to step down from her position, with effect from April 10, 2024
Erin Colgan, CFO, Sensei Biotherapeutics, will soon be leaving the company. Colgan has decided to leave her position voluntarily, with effect from April 10, 2024. There are reportedly no issues between Colgan and the business about its operations, rules or procedures.
Colgan has been an important executive at Sensei Biotherapeutics, responsible for managing the organisation’s operations and financial plan.
